SHINE Technologies

Fusion gets talked about as a physics problem. Making it work in the real world is also a manufacturing, operations, regulatory and commercialization challenge. For 16 years, we've been building experience across those disciplines in commercial markets. Testing and nuclear medicine have taught our teams what it takes to turn complex technology into something that can perform under real-world requirements. Now, as we develop technology for nuclear fuel recycling, we're carrying those lessons into the same work at a much larger scale. Each market asks something different of our teams. Each gives us more to carry forward on our path towards fusion energy. Swipe through to see the expertise behind the technology.

At one point, SHINE founder and CEO Greg Piefer was a nerdy kid who spent recess reading about particle accelerators. Years later, he studied nuclear engineering at the University of Wisconsin-Madison, even as funding for nuclear research was scarce and many of his peers pursued other fields. Greg stayed focused on fusion. One image from campus stuck with him: trains hauling mountains of coal into a heating plant that only warmed part of the university. By comparison, the fusion fuel needed to power the entire country for a year could fit in a fraction of one train. For Greg, the potential of fusion was obvious. The question was how to make it practical. That thinking eventually became SHINE, built on a simple model: start where fusion technology is useful today and build toward what's next. In his own words: "I've always been a dreamer, and I tend to see the path forward rather than the difficulty." Read the rest of his story here: https://hubs.li/Q04CjqNJ0

Gregory Beard, Director of the U.S. DOE Office of Energy Dominance Financing (EDF), and U.S. Rep. Bryan Steil visited Chrysalis last week. In April, DOE announced a conditional commitment for a loan of $263 million to help complete the facility. Greg Piefer, our Founder & CEO, walked them through the space where we’ll produce molybdenum-99 (Mo-99), the parent isotope of the technetium-99 (Tc-99m) used to diagnose heart disease and cancer. Most of the Mo-99 used in the U.S. today comes from overseas reactors, and DOE has identified Chrysalis as a key part of creating a domestic commercial source.

Many people have already benefited from nuclear science. It’s behind the heart scan that shows a cardiologist where blood is flowing. It’s behind the therapy that seeks out cancer cells while sparing much of the healthy tissue around them. Our teams work on both, along with fusion technology and new ways to recycle used nuclear fuel. That range is what this year’s Nuclear Science Week theme is about: Think Clean. Think Solutions. Think Nuclear. If you’d like to be part of that work, visit our careers page in the comments. You might be surprised how many kinds of jobs there are in nuclear!  #NuclearScienceWeek

It has been a great start to European Association of Nuclear Medicine (EANM) 2026 in Vienna. Thanks to everyone who’s stopped by Stand 409 so far. If you haven’t made it over yet, come meet our team over a complimentary gourmet coffee and tell us what your Lu-177 program needs. We’re here through Tuesday. #EANM2026

We'll be at University of Wisconsin-Platteville's Fall Career Fair on September 24, from 9AM to 12PM, in Ullsvik Hall. Last week we made a stop at University of Wisconsin-Madison, talking with students about what it's like to inspect critical components and produce medical isotopes that diagnose and treat cancer. We're also building toward nuclear fuel recycling and fusion energy, all happening right now, right here in Wisconsin. Come find us and discover how you can become a part of everything we're doing.

A good idea becomes an industry once it's been built, operated and improved enough times to get cheaper and better with each round. That's part of the conversation our founder and CEO Greg Piefer is joining in New York today. A Blueprint for Deep Tech's Next Decade, 5:10 on the main stage at The Nest Campus, with Nicolas Burkardt of Marvel Fusion and Thomas Forner of Focused Energy, moderated by Molly Taft of WIRED. They'll cover early revenue, shared risk, strategic partnerships, and the public-private infrastructure that outlasts any single company. That's work we're already doing across our platform -- through neutron testing, medical isotopes and nuclear waste recycling on the way to fusion energy -- that gives us real customers, and real manufacturing and operating experience.

Aging infrastructure, fragile supply chains, a growing nuclear waste challenge and rising energy demand are creating problems that need new solutions.   We’re already tackling some of them while building toward what comes next. Swipe through to see where we fit in.

University of Wisconsin-Madison Engineering Students, come meet a company that's already putting fusion to work. Fusion engineering jobs exist today, and a lot of them are in Wisconsin. We'll be at the UW-Madison Engineering Career Fair on September 17 from 11AM to 5PM in the Engineering Centers Building. Today, we use fusion to inspect critical parts and test electronics against radiation. We produce medical isotopes used to diagnose and treat cancer. And we're building toward nuclear fuel recycling and fusion energy, all right here in Wisconsin. Stop by to talk about everything our engineers are already doing today, and where you could fit in.

Congratulations to Argonne National Laboratory on 80 years of nuclear science! We're proud to partner with them on a wide range of recycling initiatives.